August 09, 2020 03:08 am | Updated 03:08 am IST - New Delhi
Drug firm Abbott India has reported a 54.2% rise in net profit to ₹180.35 crore for the quarter to June 2020.
The company had posted a net profit of ₹116.94 crore for the corresponding period of the previous fiscal year, Abbott India said in a late night BSE filing on Friday.
Revenue from operations stood at ₹1,064.27 crore for the quarter under consideration. It was ₹998.89 crore for the same period a year earlier.
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.
